Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

How to decide which COVID-19 patient with myocardial infarction to send to the Cath Lab? - A case series of COVID-19 patients with myocardial infarction

Iana Simova, View ORCID ProfileDenis Nikolov, Nikolay Dimitrov, Vladimir Kornovski, Vesela Tomova, Toni Vekov, Yordan Krasnaliev
doi: https://doi.org/10.1101/2021.02.07.21251081
Iana Simova
1Heart and Brain Center of Excellence University Hospital, Pleven, Bulgaria
2Bulgarian Cardiac Institute
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Denis Nikolov
1Heart and Brain Center of Excellence University Hospital, Pleven, Bulgaria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Denis Nikolov
  • For correspondence: d.nikolov88@gmail.com
Nikolay Dimitrov
1Heart and Brain Center of Excellence University Hospital, Pleven, Bulgaria
3Heart and Brain Center of Excellence University Hospital, Burgas, Bulgaria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vladimir Kornovski
3Heart and Brain Center of Excellence University Hospital, Burgas, Bulgaria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vesela Tomova
4Medical University, Pleven; UMHAT „St. Marina“, Pleven, Bulgaria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Toni Vekov
2Bulgarian Cardiac Institute
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yordan Krasnaliev
1Heart and Brain Center of Excellence University Hospital, Pleven, Bulgaria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

INTRODUCTION The Coronavirus pandemic has hit the world with its vast contagiousness, high morbidity, and mortality. Apart from the direct damage to the lung tissue, the corona virus infection is able to predispose patients to thrombotic disease, thus causing cerebral or coronary incidents.

AIMS The aim of this study was to find a clinical or laboratory parameter, that would help in distinguishing between COVID-19 patients with myocardial infarction (MI), who have an infarct-related artery (IRA) and therefore, require immediate revascularization, and those, who have no IRA.

METHODS This was a single-center, observational study of 10 consecutive patients with COVID-19, who were admitted with confirmed MI.

RESULTS In our study group the mean age was 67.5 ± 8.3 years, half of the patients were female; all of them had arterial hypertension; 8 patients (80%) had dyslipidemy; 4 (40%) had diabetes. 30% of the patients with MI did not have an IRA, and did not require pPCI. Patients with MI and IRA had significantly higher hsTrI values (48.9 ± 43.2 vs 0.6 ± 0.7, p=0.007) and exclusively typical chest pain 100% vs 0%, p=0.007), compared to patients with MI without an IRA. The ECG changes had only marginal statistical significance. Our results suggest that using a higher cut-off value for hsTrI (>7.5 times upper reference range) increases the specificity and positive predictive value for diagnosing a MI with the presence of IRA and need for pPCI, to 100%

CONCLUSION In our analysis we confirm that a higher cut-off value for hsTrI helps distinguish between COVID patients with MI, who have IRA and therefore, require immediate revascularization, compared to those, who have no IRA.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

Funded by University hospital Heart and brain - Pleven, Bulgaria

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Approval was given by the institutional review board, consisting of assoc. prof. Iana Simova (Heart and Brain Center of Excellence University Hospital, Pleven, Bulgaria; Bulgarian Cardiac Institute), prof. Nikolay Dimitrov (Heart and Brain Center of Excellence University Hospital, Pleven, Bulgaria; Heart and Brain Center of Excellence University Hospital, Burgas, Bulgaria), prof. Toni Vekov (Bulgarian Cardiac Institute) Ethics All patients signed an informed consent for coronary angiography and PCI, and for personal data analysis. The study protocol is in accordance with the Declaration of Helsinki.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Statistical analyses were performed using SPSS statistical software for Windows version 19.0. The distribution of continuous variables was tested using the Kolmogorov-Smirnov test. Normally distributed data were presented as mean +/− standard deviation (SD), whereas non-normally distributed data - as median and interquartile range (IQR) (the difference between the 25th and 75th percentile). Categorical variables were presented in percentage terms. We compared differences between groups with Independent-Samples T-Test. Sensitivity, specificity, positive and negative predictive values (PPV and NPV) were calculated according to the true positive (TP), false positive (FP), true negative (TN) and false negative (FN) results, using the following formulas: Sensitivity = TP/(TP+FN); Specificity = TN/(TN+FP); PPV = TP/(TP+FP); NPV = TN/(TN+FN). A two-tailed p value < 0.05 was considered statistically significant.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
PreviousNext
Posted February 09, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
How to decide which COVID-19 patient with myocardial infarction to send to the Cath Lab? - A case series of COVID-19 patients with myocardial infarction
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
How to decide which COVID-19 patient with myocardial infarction to send to the Cath Lab? - A case series of COVID-19 patients with myocardial infarction
Iana Simova, Denis Nikolov, Nikolay Dimitrov, Vladimir Kornovski, Vesela Tomova, Toni Vekov, Yordan Krasnaliev
medRxiv 2021.02.07.21251081; doi: https://doi.org/10.1101/2021.02.07.21251081
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
How to decide which COVID-19 patient with myocardial infarction to send to the Cath Lab? - A case series of COVID-19 patients with myocardial infarction
Iana Simova, Denis Nikolov, Nikolay Dimitrov, Vladimir Kornovski, Vesela Tomova, Toni Vekov, Yordan Krasnaliev
medRxiv 2021.02.07.21251081; doi: https://doi.org/10.1101/2021.02.07.21251081

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Cardiovascular Medicine
Subject Areas
All Articles
  • Addiction Medicine (70)
  • Allergy and Immunology (168)
  • Anesthesia (49)
  • Cardiovascular Medicine (448)
  • Dentistry and Oral Medicine (80)
  • Dermatology (55)
  • Emergency Medicine (157)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (190)
  • Epidemiology (5214)
  • Forensic Medicine (3)
  • Gastroenterology (194)
  • Genetic and Genomic Medicine (749)
  • Geriatric Medicine (76)
  • Health Economics (212)
  • Health Informatics (694)
  • Health Policy (352)
  • Health Systems and Quality Improvement (222)
  • Hematology (98)
  • HIV/AIDS (162)
  • Infectious Diseases (except HIV/AIDS) (5814)
  • Intensive Care and Critical Care Medicine (356)
  • Medical Education (102)
  • Medical Ethics (25)
  • Nephrology (80)
  • Neurology (758)
  • Nursing (43)
  • Nutrition (129)
  • Obstetrics and Gynecology (141)
  • Occupational and Environmental Health (231)
  • Oncology (475)
  • Ophthalmology (149)
  • Orthopedics (38)
  • Otolaryngology (93)
  • Pain Medicine (39)
  • Palliative Medicine (19)
  • Pathology (139)
  • Pediatrics (223)
  • Pharmacology and Therapeutics (136)
  • Primary Care Research (96)
  • Psychiatry and Clinical Psychology (853)
  • Public and Global Health (1992)
  • Radiology and Imaging (343)
  • Rehabilitation Medicine and Physical Therapy (156)
  • Respiratory Medicine (283)
  • Rheumatology (93)
  • Sexual and Reproductive Health (72)
  • Sports Medicine (75)
  • Surgery (108)
  • Toxicology (25)
  • Transplantation (29)
  • Urology (39)